Article

The fecal microbiota transplantation from drug-naïve schizophrenia patients distinctively changes gut microbiome and metabolic profiles in male and female mice

2025-09-15

Abstract excerpt

<h4>Background</h4> Emerging evidence suggests a role for the gut microbiome in schizophrenia (SCZ) and antipsychotic-induced metabolic perturbations. Using human fecal microbiota transplantation (FMT) in mice, this study investigated the role of gut microbiome in metabolic changes related to SCZ and antipsychotic (olanzapine) treatment. <h4>Methods</h4> 5-6 weeks old germ-free NIH Swiss mice of both sexes recei...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 246bd701-f384-53ca-9392-dd7d45e7df1d
DOI: 10.1101/2025.09.13.675957

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The fecal microbiota transplantation from drug-naïve schizophrenia patients distinctively changes gut microbiome and metabolic profiles in male and female miceDOI 10.1101/2025.09.13.675957Read

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping reviewSemantic proximity Read

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in MouseSemantic proximity Read

Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in miceSemantic proximity Read

Gut microbiota serve as a risk predictor of weight gain in schizophrenia patients with antipsychotic medicationSemantic proximity Read

Role of short-chain fatty acids in the gut-brain axis in schizophrenia: contribution to immune activation and pathophysiology in humans and miceSemantic proximity Read

The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional studySemantic proximity Read

Donor Microbiota Metabolic Capacity Determines Engraftment Dynamics and Modulates Gut–Brain Signaling in Recipient MiceSemantic proximity Read

Metagenome-wide association of gut microbiome features for schizophreniaSemantic proximity Read

Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in miceSemantic proximity Read

The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic TreatmentSemantic proximity Read

Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional studySemantic proximity Read

Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?Semantic proximity Read